A First-in-Human Evaluation of a Novel Mesh-Covered Stent for Treatment of Carotid Stenosis in Patients at High Risk for Endarterectomy: 30-Day Results of the SCAFFOLD Trial.

Peter A Schneider,Elad Levy,J Michael Bacharach,D Christopher Metzger,Bryan Randall,Andrew Garcia,Adnan Siddiqui,Claudio Schonholz,William Gray

JACC: Cardiovascular Interventions（2018）

引用 15|浏览19

暂无评分

摘要

Low death, stroke, or MI rates were demonstrated with GCS in patients at high risk for CEA. The 30-day stroke rate of 1.1% suggests that the carotid stent mesh covering may reduce the neurologic events associated with CAS when used in appropriately selected patients.

查看译文

关键词

carotid artery disease,carotid artery stent,carotid endarterectomy,clinical studies,GORE carotid stent,high risk,stent design/structure/coatings,stroke

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要